BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 18061182)

  • 1. Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosis.
    Nahon P; Sutton A; Rufat P; Ziol M; Thabut G; Schischmanoff PO; Vidaud D; Charnaux N; Couvert P; Ganne-Carrie N; Trinchet JC; Gattegno L; Beaugrand M
    Gastroenterology; 2008 Jan; 134(1):102-10. PubMed ID: 18061182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HFE gene mutations in alcoholic and virus-related cirrhotic patients with hepatocellular carcinoma.
    Lauret E; Rodríguez M; González S; Linares A; López-Vázquez A; Martínez-Borra J; Rodrigo L; López-Larrea C
    Am J Gastroenterol; 2002 Apr; 97(4):1016-21. PubMed ID: 12003382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased incidence of HFE C282Y mutations in patients with iron overload and hepatocellular carcinoma developed in non-cirrhotic liver.
    Blanc JF; De Ledinghen V; Bernard PH; de Verneuil H; Winnock M; Le Bail B; Carles J; Saric J; Balabaud C; Bioulac-Sage P
    J Hepatol; 2000 May; 32(5):805-11. PubMed ID: 10845668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron overload and HFE gene mutations in Polish patients with liver cirrhosis.
    Sikorska K; Romanowski T; Stalke P; Iżycka-Świeszewska E; Bielawski KP
    Hepatobiliary Pancreat Dis Int; 2011 Jun; 10(3):270-5. PubMed ID: 21669570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between heterozygosity for HFE gene mutations and hepatitis viruses in hepatocellular carcinoma.
    Fracanzani AL; Fargion S; Stazi MA; Valenti L; Amoroso P; Cariani E; Sangiovanni A; Tommasini M; Rossini A; Bertelli C; Fatta E; Patriarca V; Brescianini S; Stroffolini T
    Blood Cells Mol Dis; 2005; 35(1):27-32. PubMed ID: 15894495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations of the HFE gene and the risk of hepatocellular carcinoma.
    Racchi O; Mangerini R; Rapezzi D; Gaetani GF; Nobile MT; Picciotto A; Ferraris AM
    Blood Cells Mol Dis; 1999; 25(5-6):350-3. PubMed ID: 10660482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HFE C282Y heterozygosity in hepatocellular carcinoma: evidence for an increased prevalence.
    Hellerbrand C; Pöppl A; Hartmann A; Schölmerich J; Lock G
    Clin Gastroenterol Hepatol; 2003 Jul; 1(4):279-84. PubMed ID: 15017669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of association between HFE gene mutations and hepatocellular carcinoma in patients with cirrhosis.
    Boige V; Castéra L; de Roux N; Ganne-Carrié N; Ducot B; Pelletier G; Beaugrand M; Buffet C
    Gut; 2003 Aug; 52(8):1178-81. PubMed ID: 12865278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of association of primary iron overload and common HFE gene mutations with liver cirrhosis in adult Indian population.
    Jain S; Agarwal S; Tamhankar P; Verma P; Choudhuri G
    Indian J Gastroenterol; 2011 Jul; 30(4):161-5. PubMed ID: 21822737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mutations in the HFE gene (C282Y, H63D, S65C) in alcoholic patients with finding of iron overload].
    Campos Franco J; González Quintela A; Fernández de Trocóniz LL; Barros Angueira F; Pérez-Quintela BV; Pérez Becerra E; Martínez de Rituerto ST; Otero Antón E; Torre Carballada JA
    Rev Clin Esp; 2002 Oct; 202(10):534-9. PubMed ID: 12361551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations of the HFE gene in patients with hepatocellular carcinoma.
    Cauza E; Peck-Radosavljevic M; Ulrich-Pur H; Datz C; Gschwantler M; Schöniger-Hekele M; Hackl F; Polli C; Rasoul-Rockenschaub S; Müller C; Wrba F; Gangl A; Ferenci P
    Am J Gastroenterol; 2003 Feb; 98(2):442-7. PubMed ID: 12591066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the HFE gene and their interaction with exogenous risk factors in hepatocellular carcinoma.
    Fargion S; Stazi MA; Fracanzani AL; Mattioli M; Sampietro M; Tavazzi D; Bertelli C; Patriarca V; Mariani C; Fiorelli G
    Blood Cells Mol Dis; 2001; 27(2):505-11. PubMed ID: 11500061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary hemochromatosis in a Brazilian university hospital in São Paulo State (1990-2000).
    Martinelli AL; Filho R; Cruz S; Franco R; Tavella M; Secaf M; Ramalho L; Zucoloto S; Rodrigues S; Zago M
    Genet Mol Res; 2005 Mar; 4(1):31-8. PubMed ID: 15841433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HFE gene mutations in Polish patients with disturbances of iron metabolism: an initial assessment.
    Sikorska K; Bielawski KP; Stalke P; Lakomy EA; Michalska Z; Witczak-Malinowska K; Romanowski T
    Int J Mol Med; 2005 Dec; 16(6):1151-6. PubMed ID: 16273299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of HFE C282Y gene mutation is increased in Spanish patients with porphyria cutanea tarda without hepatitis C virus infection.
    Toll A; Celis R; Ozalla MD; Bruguera M; Herrero C; Ercilla MG
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1201-6. PubMed ID: 17062032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic iron overload and risk of hepatocellular carcinoma in cirrhosis.
    Nahon P; Ganne-Carrié N; Trinchet JC; Beaugrand M
    Gastroenterol Clin Biol; 2010 Jan; 34(1):1-7. PubMed ID: 19762191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic iron overload in alcoholic end-stage liver disease is associated with iron deposition in other organs in the absence of HFE-1 hemochromatosis.
    Eng SC; Taylor SL; Reyes V; Raaka S; Berger J; Kowdley KV
    Liver Int; 2005 Jun; 25(3):513-7. PubMed ID: 15910487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis.
    Erhardt A; Maschner-Olberg A; Mellenthin C; Kappert G; Adams O; Donner A; Willers R; Niederau C; Häussinger D
    J Hepatol; 2003 Mar; 38(3):335-42. PubMed ID: 12586300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron-overload-related disease in HFE hereditary hemochromatosis.
    Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM
    N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemochromatosis and transferrin receptor gene polymorphisms in chronic hepatitis C: impact on iron status, liver injury and HCV genotype.
    Gehrke SG; Stremmel W; Mathes I; Riedel HD; Bents K; Kallinowski B
    J Mol Med (Berl); 2003 Dec; 81(12):780-7. PubMed ID: 14557859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.